Chronic AC comprises a spectrum of diseases including AKC and VKC which compromise vision. Corneal ulceration and neovascularization are frequent consequences of these chronic diseases, and treatment with a conventional mast cell stabilizer is often unsatisfactory. New and effective therapeutic strategies for chronic AC patients depend on achieving a greater understanding of the role of the cell populations and their interaction in these sight-threatening disorders. Each condition is characterized by a complex immunopathology with a mixed cellular infiltrate, and can not be explained by type 1 hypersensitivity alone. Recent studies have accumulated evidence for the involvement of T cell-mediated inflammation in the initiation and perpetuation of chronic AC (1,5,14,20,23). We also have investigated the role of T cells in EC (6,17,22). In a previous report, we investigated the ability of Ag-specific T cell activation to induce EC in Brown Norway (BN) rats. Using BN rats, we generated Ag-specific T cells labeled with 5-(and 6-) carboxyfluorescein diacetate succinimidyl ester (CFSE) and transferred them into syngeneic rats, and proved that CFSE-labeled Ag-specific T cells were present in the conjunctiva from 6 to 48 hr after Ag challenge
Detection of Antigen-Specific T Cells in